Zhou et al. reported that activating 7 nicotinic acetylcholine receptor, the mediator of cholinergic anti-inflammation pathway, suppressed the release of TNF-α and IL-6 in a mouse NASH model. This evidence concerns the gene TNF and metabolic dysfunction-associated steatohepatitis.